Sökresultat

Khujand Polytechnic Institute of Tajik Technical University (KPITTU) is a young, expanding institution in Tajikistan with great potential for development. Today, it is working resolutely to develop its research, guaranteeing the quality of its operational activities and extending the scope of its international networking. KPITTU is ranked number 1 in Central Asia in the use of Information Technolo

https://www.centralasianlaw.lu.se/khujand-polytechnic-institute-tajik-technical-university - 2026-05-05

SIAR research & consulting (SIAR) is an international research and consulting company based in Bishkek, Kyrgyzstan and provides professional services in the countries of Central Asia, Caucasus, Mongolia, China and Afghanistan in the areas of social and marketing research and executive consulting. SIAR research & consulting develops the full range of its services – from the development of research

https://www.centralasianlaw.lu.se/siar-research-consulting - 2026-05-05

The Academy of the General Prosecutors Office (AGPO) of the Republic of Uzbekistan was established in 1992. The Academy is an educational and research institution. The main goal of the Academy is to organize an effective system of training, retraining and advanced training of employees of the prosecutor’s office and other personnel, as well as to conduct fundamental and applied scientific research

https://www.centralasianlaw.lu.se/academy-general-prosecutors-office - 2026-05-05

Tebigy Kuwwat Social Unit Enterprise functions in Turkmenistan since 2003 in accordance with the current legislation of Turkmenistan and the State programmes on environment protection. The activities of Tebigy Kuwwat cover the following fields: providing information to State Authorities on environment protection; distribution of the experience in innovative technologies and best practice for susta

https://www.centralasianlaw.lu.se/tebigy-kuwwat-social-unit-enterprise - 2026-05-05

What is the difference between the market and the bazaar? Is the difference only in the origin of the words, or do they define any relationship specificities unique to culture of their origin? Will the laws and rules that govern market relationships in the West are also applicable to the Central Asian region where everyday life and social relations revolve around informal practices and transaction

https://www.centralasianlaw.lu.se/cal-project/about - 2026-05-05

“Central Asian Law: Legal Cultures and Business Environments in Central Asia” is a 4-year research and training project funded by the European Commission’s H2020 MSCA-RISE programme (project number 870647), which runs from 01/03/2020 through 28/02/2024. The project aims to produce new knowledge and policy insights on the interlinkages between legal cultures, governance and business environment in

https://www.centralasianlaw.lu.se/cal-project - 2026-05-05

To understand how national and international laws, norms, and (written and unwritten) rules shape the business environment in the five Central Asian countries International actors: the role and influence of transnational and international actors on institutional and business environments of the Central Asian region Domestic institutions: the nexus between legal environment, domestic regulatory ins

https://www.centralasianlaw.lu.se/cal-project/research-objectives - 2026-05-05

Economic relations between EU and Central Asian countries Challenging business environment: inconsistent business ethics and weak rule-of-law Lack of understanding of the interconnections between legal cultures, local business environments and governance in Central Asia Lack of specialists and intelligence focusing on Central Asian legal cultures and business environment

https://www.centralasianlaw.lu.se/cal-project/project-rationale - 2026-05-05

Edited Volumes, Monographs and Research Reports Urinboyev, R. and Svensson, M., (2022, forthcoming). Law, Society and Corruption: Lessons from the Post-Soviet Context. Routledge (Law, Justice and Power Series)   Turaeva, R. and Urinboyev, R., eds., (2021). Labour, Mobility and Informal Practices in Russia, Central Asia and Eastern Europe. Routledge (BASEES Series) https://www.routledge.com/Labour-

https://www.centralasianlaw.lu.se/books - 2026-05-05

https://www.clinicalgenetics.lu.se/department-clinical-genetics-0 - 2026-05-05

 The immune system has a remarkable capacity to scan tissues to recognize and eliminate abnormal and malignant cells. Scientific advances now allow us to improve and utilize this strength of the immune system against tumors.Our goal is to advance our ability to treat cancer using cell-based immunotherapy. By developing state-of-art genetic circuits and synthetic biology we strive to bring forward

https://www.clinicalgenetics.lu.se/axel-hyrenius-wittsten - 2026-05-05

https://www.clinicalgenetics.lu.se/startsidan - 2026-05-05

https://www.clinicalgenetics.lu.se/department-clinical-genetics-1 - 2026-05-05

Translating genomic discoveries into improved clinical decision making, mechanistic understanding, and therapy of acute leukemia The overall objective of our research is to significantly improve the way in which acute leukemia is diagnosed, understood at the functional/molecular level, and treated within health care.We work in three highly aligned and synergistic projects. In the first, new and cl

https://www.clinicalgenetics.lu.se/division-clinical-genetics/fioretos-research-group - 2026-05-05

  With a basis in stem cell biology, genetics, immunology and cancer research, our mission is to develop innovative immunotherapies that effectively target leukemia and other malignancies. To achieve this goal, we work on the following projects:•    Unravel immune evasion mechanisms in cancer. •    Development of therapeutic antibodies directed to novel targets.•    Development of CAR-macrophages

https://www.clinicalgenetics.lu.se/division-clinical-genetics/jaras-research-group - 2026-05-05

  We focus on understanding the pathogenetic mechanisms underlying leukemogenesis with a special focus on infant leukemia. In particular we are interested in unravelling the biological mechanisms that drive clonal evolution, the emergence of drug resistance, and the role of tumor heterogeneity in these processes, ultimately leading to new effective therapies. We use a combination of state-of-the-a

https://www.clinicalgenetics.lu.se/division-clinical-genetics/anna-hagstrom - 2026-05-05

    We make genetic and functional maps of cancer cell evolution in patients by analysing multiple tumour samples from the same patient. In particular, we focus on childhood cancer where we try to unravel the genetic mechanisms leading to relapse and treatment resistance.To achieve our aim, we use methods from species evolution (phylogenetics) to reconstruct the evolutionary history of individual

https://www.clinicalgenetics.lu.se/division-clinical-genetics/cancer-cell-evolution - 2026-05-05

The Database of Chromosome Aberrations and Gene Fusions in Cancer, established in 1980, is an attempt to register systematically all published cytogenetic aberrations reported in cancer, including patient and tumor characteristics, gene fusions identified by cytogenetics or massively parallel sequencing, and studies pertaining to the clinical relevance of cytogenetic aberrations and/or gene rearra

https://www.clinicalgenetics.lu.se/division-clinical-genetics/database-chromosome-aberrations-and-gene-fusions-cancer - 2026-05-05

  Soft tissue tumors (STT) constitute a heterogeneous group of approximately 100 distinct neoplasms, including more than 50 malignant subtypes, so-called sarcomas. Genetic analyses have shown that the clinical and biological variation among these neoplasms is reflected in their genotypes. While the diagnosis of STT has been improved by such genetic biomarkers, the use of genetic information for im

https://www.clinicalgenetics.lu.se/division-clinical-genetics/genetics-soft-tissue-tumors - 2026-05-05

The goal of our research is to increase our understanding of the leukemogenic process and to investigate the clinical impact of genetic/epigenetic abnormalities in pediatric acute lymphoblastic and myeloid leukemia. In order to achieve this goal, we use several types of “next generation sequencing”, such as whole genome sequencing, whole exome sequencing, and RNA sequencing, and various methylatio

https://www.clinicalgenetics.lu.se/division-clinical-genetics/geneticsepigenetics-pediatric-leukemia - 2026-05-05